A Phase 2 Study of Tasisulam Sodium (LY573636 Sodium) as Second-Line Treatment for Patients With Unresectable or Metastatic MelanomaKIRKWOOD, John M; GONZALEZ, Rene; REINTGEN, Douglas et al.Cancer. 2011, Vol 117, Num 20, pp 4732-4739, issn 0008-543X, 8 p.Article

Malignant melanoma in the 21st century, Part 2: Staging, prognosis, and treatmentMARKOVIC, Svetomir N; ERICKSON, Lori A; LAMAN, Susan D et al.Mayo Clinic proceedings. 2007, Vol 82, Num 4, pp 490-513, issn 0025-6196, 24 p.Article

Risk of malignancy in first-degree relatives of patients with pancreatic carcinomaMCWILLIAMS, Robert R; RABE, Kari G; OLSWOLD, Curtis et al.Cancer. 2005, Vol 104, Num 2, pp 388-394, issn 0008-543X, 7 p.Article

Genes-Environment Interactions in Obesity- and Diabetes-Associated Pancreatic Cancer: A GWAS Data AnalysisHONGWEI TANG; PENG WEI; MCWILLIAMS, Robert R et al.Cancer epidemiology, biomarkers & prevention. 2014, Vol 23, Num 1, pp 98-106, issn 1055-9965, 9 p.Article

Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counselingMCWILLIAMS, Robert R; WIEBEN, Eric D; RABE, Kari G et al.European journal of human genetics. 2011, Vol 19, Num 4, pp 472-478, issn 1018-4813, 7 p.Article

Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma : The Mayo Clinic Experience (1975-2005)CORSINI, Michele M; MILLER, Robert C; LOTT, Matthew J et al.Journal of clinical oncology. 2008, Vol 26, Num 21, pp 3511-3516, issn 0732-183X, 6 p.Article

Mitochondrial Genetic Polymorphisms Do Not Predict Survival in Patients with Pancreatic CancerHALFDANARSON, Thorvardur R; LIANG WANG; BAMLET, William R et al.Cancer epidemiology, biomarkers & prevention. 2008, Vol 17, Num 9, pp 2512-2513, issn 1055-9965, 2 p.Article

A Randomized Phase 2 Study of Temozolomide and Bevacizumab or nab-Paclitaxel, Carboplatin, and Bevacizumab in Patients With Unresectable Stage IV Melanoma: A North Central Cancer Treatment Group Study, N0775KOTTSCHADE, Lisa A; SUMAN, Vera J; KOSEL, Matthew L et al.Cancer. 2013, Vol 119, Num 3, pp 586-592, issn 0008-543X, 7 p.Article

Association of Mitotic Regulation Pathway Polymorphisms with Pancreatic Cancer Risk and OutcomeCOUCH, Fergus J; XIANSHU WANG; BAMLET, William R et al.Cancer epidemiology, biomarkers & prevention. 2010, Vol 19, Num 1, pp 251-257, issn 1055-9965, 7 p.Article

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutations and Risk for Pancreatic AdenocarcinomaMCWILLIAMS, Robert R; PETERSEN, Gloria M; RABE, Kari G et al.Cancer. 2010, Vol 116, Num 1, pp 203-209, issn 0008-543X, 7 p.Article

Obesity Adversely Affects Survival in Pancreatic Cancer PatientsMCWILLIAMS, Robert R; MATSUMOTO, Martha E; BURCH, Patrick A et al.Cancer. 2010, Vol 116, Num 21, pp 5054-5062, issn 0008-543X, 9 p.Article

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancerAMUNDADOTTIR, Laufey; KRAFT, Peter; LACROIX, Andrea et al.Nature genetics. 2009, Vol 41, Num 9, pp 986-990, issn 1061-4036, 5 p.Article

Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147GONSALVES, Wilson I; MAHONEY, Michelle R; HUBBARD, Joleen M et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 7, issn 0027-8874, dju106.1-dju106.8Article

Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancerDONGHUI LI; DUELL, Eric J; ARSLAN, Alan A et al.Carcinogenesis (New York. Print). 2012, Vol 33, Num 7, pp 1384-1390, issn 0143-3334, 7 p.Article

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33PETERSEN, Gloria M; AMUNDADOTTIR, Laufey; HELZLSOUER, Kathy et al.Nature genetics. 2010, Vol 42, Num 3, pp 224-228, issn 1061-4036, 5 p.Article

A single-institution experience with 491 cases of small bowel adenocarcinomaHALFDANARSON, Thorvardur R; MCWILLIAMS, Robert R; DONOHUE, John H et al.The American journal of surgery. 2010, Vol 199, Num 6, pp 797-803, issn 0002-9610, 7 p.Article

Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved ChemotherapyKOPETZ, Scott; CHANG, George J; OVERMAN, Michael J et al.Journal of clinical oncology. 2009, Vol 27, Num 22, pp 3677-3683, issn 0732-183X, 7 p.Article

Nucleotide Excision Repair Pathway Polymorphisms and Pancreatic Cancer Risk: Evidence for role of MMS19LMCWILLIAMS, Robert R; BAMLET, William R; DE ANDRADE, Mariza et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 4, pp 1295-1302, issn 1055-9965, 8 p.Article

Association of Breast Cancer Susceptibility Variants with Risk of Pancreatic CancerCOUCH, Fergus J; XIANSHU WANG; MCWILLIAMS, Robert R et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 11, pp 3044-3048, issn 1055-9965, 5 p.Article

Malignant melanoma in the 21st century, Part 1: Epidemiology, risk factors, screening, prevention, and diagnosisMARKOVIC, Svetomir N; ERICKSON, Lori A; LAMAN, Susan D et al.Mayo Clinic proceedings. 2007, Vol 82, Num 3, pp 364-380, issn 0025-6196, 17 p.Article